Company Name Date of Filing Time of Filing Document Type File Format File Size

NervGen Pharma Corp.


Jul 5 2019

17:10:09 ET

News release - English

PDF

34 K  


Jun 27 2019

15:30:14 ET

Notice of the meeting and record date - English

PDF

108 K  


Jun 26 2019

16:52:40 ET

Statement of Executive Compensation (Form 51-102F6V) - English

PDF

214 K  


Jun 26 2019

09:04:27 ET

News release - English

PDF

38 K  


Jun 10 2019

07:11:04 ET

News release - English

PDF

36 K  


Jun 3 2019

08:34:35 ET

News release - English

PDF

37 K  


May 30 2019

09:04:17 ET

News release - English

PDF

43 K  


May 29 2019

14:18:58 ET

News release - English

PDF

156 K  


May 24 2019

14:34:45 ET

MD&A - English

PDF

271 K  


May 24 2019

14:33:58 ET

Interim financial statements/report - English

PDF

265 K  


May 24 2019

14:32:13 ET

52-109FV2 - Certification of interim filings - CEO (E)

PDF

211 K  


May 24 2019

14:32:13 ET

52-109FV2 - Certification of interim filings - CFO (E)

PDF

209 K  


May 6 2019

14:34:29 ET

Report of exempt distribution excluding Schedule 1 of 45-106F1

PDF

504 K  


May 3 2019

12:36:07 ET

Cover letter

PDF

156 K  


May 1 2019

15:31:38 ET

News release - English

PDF

156 K  


Apr 24 2019

12:01:01 ET

News release - English

PDF

181 K  


Apr 23 2019

17:51:13 ET

News release - English

PDF

143 K  


Apr 23 2019

12:47:25 ET

News release - English

PDF

144 K  


Apr 1 2019

08:38:27 ET

News release - English

PDF

49 K  


Mar 20 2019

17:35:11 ET

52-109FV1 - Certification of annual filings - CEO (E)

PDF

15 K  


Mar 20 2019

17:35:11 ET

52-109FV1 - Certification of annual filings - CFO (E)

PDF

15 K  


Mar 20 2019

17:32:42 ET

MD&A - English

PDF

164 K  


Mar 20 2019

17:28:48 ET

AB Form 13-501F2 (Class 2 Reporting Issuers - Participation Fee)

PDF

40 K  


Mar 20 2019

17:28:48 ET

Audited annual financial statements - English

PDF

154 K  


Mar 14 2019

19:33:08 ET

News release - English

PDF

144 K  


Mar 13 2019

16:10:36 ET

News release - English

PDF

150 K  


Feb 19 2019

19:46:37 ET

Non-issuer's submission to jurisdiction and appointment of agent

PDF

10 K  


Feb 19 2019

19:46:37 ET

Non-issuer's submission to jurisdiction and appointment of agent

PDF

10 K  


Feb 19 2019

19:30:15 ET

Other material contract(s)

PDF

92 K  


Feb 19 2019

18:50:59 ET

Decision Document (Final)

PDF

15 K  


Feb 19 2019

16:59:29 ET

Auditors' consent letter

PDF

104 K  


Feb 19 2019

16:59:29 ET

Consent letter(s) of other legal counsel

PDF

51 K  


Feb 19 2019

16:59:29 ET

Escrow agreement

PDF

126 K  


Feb 19 2019

16:59:29 ET

Final long form prospectus - English

PDF

1402 K  


Feb 19 2019

16:59:29 ET

Other material contract(s)

PDF

26 K  


Feb 19 2019

16:59:29 ET

Underwriting or agency agreement

PDF

161 K  


Jan 30 2019

19:26:31 ET

Other material contract(s)

PDF

29 K  


Jan 30 2019

19:11:21 ET

Marketing materials - English

PDF

2700 K  


Jan 28 2019

20:43:27 ET

Escrow agreement

PDF

87 K  


Nov 20 2018

12:12:49 ET

Decision Document (Preliminary)

PDF

21 K  


Nov 19 2018

17:30:08 ET

Documents affecting rights of securityholders (or amendment thereto)

PDF

131 K  


Nov 19 2018

17:30:08 ET

Documents affecting rights of securityholders (or amendment thereto)

PDF

291 K  


Nov 19 2018

17:30:08 ET

Documents affecting rights of securityholders (or amendment thereto)

PDF

149 K  


Nov 19 2018

17:30:08 ET

Documents affecting rights of securityholders (or amendment thereto)

PDF

289 K  


Nov 19 2018

17:30:08 ET

Documents affecting rights of securityholders (or amendment thereto)

PDF

130 K  


Nov 19 2018

17:30:08 ET

Preliminary long form prospectus - English

PDF

1493 K  


Sep 13 2018

19:27:18 ET

Report of exempt distribution excluding Schedule 1 of 45-106F1

PDF

360 K